• Title/Summary/Keyword: remission

Search Result 587, Processing Time 0.026 seconds

Acute Pulmonary Mycetoma Due to Candida albicans in AML patient : Case Report (급성 백혈병 환자에서 Candida에 의한 급성 폐진균 감염)

  • Lee, Jae-Kyo;Hwang, Mi-Soo;Kim, Mi-Jin
    • Journal of Yeungnam Medical Science
    • /
    • v.12 no.1
    • /
    • pp.135-140
    • /
    • 1995
  • Acute cavitating pulmonary infection with a mycetoma is sometimes occur in immunocompromised patient. Most mycetoma lesions are due to Aspergillus species, and lesion caused by Candida species is rare. So we report an experienced case that pulmonary and rib infection caused by Candida species in AML patient and complete remission with previous reports.

  • PDF

A Case of Chronic Adult Atopic Dermatitis (만성 성인형 아토피 피부염의 외치 1례)

  • Sim, Sung-yong;Kim, Sung-beum;Kim, Kyung-jun
    • The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
    • /
    • v.16 no.1
    • /
    • pp.179-190
    • /
    • 2003
  • Atopic dermatitis is a chronic, inflammatory skin disease characterized by intense pruritus and the course marked by exacerbation and remission. It has the characteristic symptoms of dry, itchy, scaly skin with cracks by typical distribution of lesions. Even though the etiology of atopic dermatitis is not fully understood, it is considered an allergic reaction whose onset is frequently and strongly associated with both hereditary and environmental factors. In the present clinical study, we studied the efficacy of internal herb-medicine, external herb medicine - ex. dermal oints, aqueous solutions, etc -, and steam therapy. The patient's SCORAD index was lowered 55.8 than before of which the SCORAD index was 74.8. On the basis of this study, it should be considered that the treatment of atopic dermatitis should be focused on the external therapy as steam therapy, dermal oint, a aqueous solution etc.

  • PDF

Real-Time Fluorescence Imaging in Thoracic Surgery

  • Das, Priyanka;Santos, Sheena;Park, G. Kate;I, Hoseok;Choi, Hak Soo
    • Journal of Chest Surgery
    • /
    • v.52 no.4
    • /
    • pp.205-220
    • /
    • 2019
  • Near-infrared (NIR) fluorescence imaging provides a safe and cost-efficient method for immediate data acquisition and visualization of tissues, with technical advantages including minimal autofluorescence, reduced photon absorption, and low scattering in tissue. In this review, we introduce recent advances in NIR fluorescence imaging systems for thoracic surgery that improve the identification of vital tissues and facilitate the resection of tumorous tissues. When coupled with appropriate NIR fluorophores, NIR fluorescence imaging may transform current intraoperative thoracic surgery methods by enhancing the precision of surgical procedures and augmenting postoperative outcomes through improvements in diagnostic accuracy and reductions in the remission rate.

Endoscopic features aiding the diagnosis of gastric mucosa-associated lymphoid tissue lymphoma

  • Park, Byung Sam;Lee, Si Hyung
    • Journal of Yeungnam Medical Science
    • /
    • v.36 no.2
    • /
    • pp.85-91
    • /
    • 2019
  • The incidence of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is increasing worldwide, but the diagnosis is difficult. Most patients are asymptomatic or complain of nonspecific gastrointestinal symptoms. As the endoscopic features of gastric MALT lymphoma are variable and nonspecific, the possibility of this condition may be overlooked during esophagogastroduodenoscopy, and it remain undiagnosed. Therefore, this condition needs to be considered when an abnormal mucosa is observed during this procedure. Biopsy performed during endoscopy is the primary diagnostic test, but false negative results are possible; large numbers of samples should be collected from both normal and abnormal mucosae. Endoscopic ultrasonography is useful to assess the depth of invasion and to predict the treatment response. After treatment, follow-up tests are required every 3 months until complete remission is achieved, and annually thereafter. Early diagnosis of gastric MALT lymphoma is difficult, and its diagnosis and follow-up require wide experience and competent endoscopic technique.

Novel Association of a Familial TGFBR1 Mutation in Loeys-Dietz Syndrome with Concomitant Hematologic Malignancy

  • Disha, Kushtrim;Schulz, Solveig;Breuer, Martin;Owais, Tamer;Girdauskas, Evaldas;Kuntze, Thomas
    • Journal of Chest Surgery
    • /
    • v.52 no.5
    • /
    • pp.376-379
    • /
    • 2019
  • Concomitant Loeys-Dietz syndrome (LDS) and hematologic malignancies are exceptionally rare. This is the first report of a patient operated on for aortic root dilation who had been previously diagnosed with LDS and B-cell-lymphoma. After completion of chemotherapy and complete remission, an elective valve-sparing aortic root replacement (using the David-V method) was performed. Due to the positive family history, preoperative genetic counseling was conducted, and revealed LDS with a TGFBR1 (transforming growth factor beta receptor type I) mutation in 6 probands of the family, albeit in 1 of them posthumously. This missense mutation has been previously described in relation to aortic dissection, but a causative relationship to malignancy has so far neither been proposed nor proven.

Dendritic Cell as an effective cancer immuno-cell therapy module I. : Anti-tumor effect of cultured DCs in murine leukemia model

  • In, So-Hee;Kim, Myung-Ju;Baek, So-Young;Lee, Hong-Gi;Kim, Ki-Hyun;Lee, Hyun-Ah
    • Proceedings of the PSK Conference
    • /
    • 2003.10b
    • /
    • pp.130.1-130.1
    • /
    • 2003
  • As a potent antigen presenting cells and a powerful inducer of antigen specific immunity including cytotoxic T cell activity, dendritic cells(DCs) are being considered as a promising anti-tumor therapeutic module. Unlike solid tumors, leukemia is the hematologic malignancy involving immune effector cells. The expected usage of DCs in leukemia is the treatment of minimal residual disease(MRD) after the remission or stem cell transplantation. In this study, syngeneic leukemia cells were inoculated intra-venously into the mouse (WEHI-3 into the Balb/c), and the autologous tumor cell lysate pulsed DCs were injected as a therapeutic module twice in two weeks. (omitted)

  • PDF

Successful management of systemic lupus erythematosus with levamisole in a Dachshund dog

  • Kim, Dong-Hyun;Han, Hyun-Jung;Kim, Jung-Hyun
    • Korean Journal of Veterinary Research
    • /
    • v.61 no.1
    • /
    • pp.1.1-1.5
    • /
    • 2021
  • A 5-year-old neutered female Dachshund dog presented with a 3-month history of hyperthermia, skin lesions, and shifting lameness. Based on physical examination, blood tests, urinalysis, and radiographs, the dog was diagnosed with systemic lupus erythematosus. Clinical signs improved after administration of prednisolone and cyclosporine but relapsed after the prednisolone was reduced due to side effects. Oral levamisole was commenced and the other immunosuppressants were tapered over a period of 2 months and then stopped. Levamisole was retained as the sole therapy for an additional 2 months. Six months after discontinuation of all treatment, the patient remained in remission.

Lacrimal sac lymphoma: a case report

  • Ueathaweephol, Somtaporn;Wongwattana, Panuwat;Chanlalit, Waruttaporn;Trongwongsa, Therdkiat;Sutthinont, Sirilak
    • Archives of Craniofacial Surgery
    • /
    • v.23 no.1
    • /
    • pp.43-47
    • /
    • 2022
  • Primary lymphoma originating from the lacrimal drainage system is a rare disease. Such lymphomas are mostly B-cell in origin and present nonspecific symptoms. The treatment of malignant lymphoma of the lacrimal drainage system is slightly different. We present the case of a 71-year-old woman with a painless mass below the medial canthus. Computed tomography (CT) scan of the orbit revealed a mass invading the right lacrimal sac. An incision biopsy was obtained, and the pathologic findings suggested a diagnosis of primary diffuse large B-cell lymphoma of the lacrimal sac. The patient was treated with chemotherapy and intrathecal methotrexate. After completing eight cycles of chemotherapy, the patient was followed up by a CT scan, which revealed nearly total resolution of an ill-defined enhancing mass. At the time of this case report writing, the patient is in complete remission at six months with no other complications.

Recent Update on the Treatment of Colorectal Peritoneal Metastasis: A Surgical Perspective

  • Hye Jung Cho;Woo Ram Kim
    • Journal of Digestive Cancer Research
    • /
    • v.10 no.2
    • /
    • pp.74-81
    • /
    • 2022
  • Colorectal peritoneal metastasis has been an incurable disease for centuries. However, since the new millennium, recent advancements in therapies are achieved with modern chemotherapeutic agents, target agents, and immune checkpoint blockade introduction. Modern chemotherapies, from a nearly nonexistent median survival if untreated, have raised the duration to 16 months with target agents. Experts have once again surpassed its limit by introducing intraperitoneal chemotherapy and cytoreductive surgery (CRS). Numerous clinical trials regarding CRS and hyperthermic intraperitoneal chemotherapy have now opened new doors in peritoneal carcinomatosis treatment, even securing complete remission. In addition, up-to-date modalities, such as pressurized intraperitoneal aerosol chemotherapy and immunotherapies, showed promising results at an early stage.

Nutritional Assessment and Nutritional Management for GI Cancer Patients

  • Mi Hyang Um;Yoo Kyoung Park
    • Journal of Digestive Cancer Research
    • /
    • v.2 no.1
    • /
    • pp.15-20
    • /
    • 2014
  • Cancer, especially GI cancer itself and any associated treatments have profound effect on the patient's nutritional status. It is therefore very important to understand various nutritional issues in GI cancer patients for the cure and for increasing the compliance during the course of the treatment. Screening and identification of nutritional risk for the GI cancer patients is very essential and is plays a critical part of the treatment to help improve patient outcomes. Maintaining optimal nutritional status is an important goal in the management of individuals diagnosed, treated with cancer. Maintenance of adequate nutritional intake is important whether patients are undergoing active therapy, recovering from cancer therapy, or are in remission and striving to avoid cancer recurrence. The goals of nutrition therapy are to prevent or reverse nutrient deficiencies, preserve lean body mass, help patients better tolerate treatments and minimize nutrition-related side effects and complications, etc. Recent interest in clinical settings is also in maximizing quality of life of the patients which can also be modulated by appropriate nutrition.

  • PDF